 ASHBURN, Va., Aug. 11, 2022 GLOBE NEWSWIRE -- Quoin Pharmaceuticals Ltd. NASDAQ: QNRX the Company or Quoin, a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its second quarter 2022 financial results will be reported on Thursday, August 18, 2022 before the open of the financial markets. Management will also host a webcast and conference call on August 18, 2022 at 8:30 a.m. ET to discuss the results and provide a corporate update. 